no-title January 19, 2018 no-title Trade Name Cerebrolysin Orphan Indication Frontotemporal dementia, including all subvariants USA Market Approval USA USA Designation Date 2016-04-05 00:00:00 Sponsor EVER Neuro Pharma GmbH;3 Oberburgau, 4866 Unterach;
